Quality analysis of proprietary Chinese medicines containing ginseng (red ginseng) based on 2021—2024 national drug sampling and testing*

HE Feng-yan, GUO Ri-xin, ZHOU Ya-nan, WANG Ya-nan, LIU Jing, WEI Feng

Chinese Journal of Pharmaceutical Analysis ›› 2026, Vol. 46 ›› Issue (3) : 415-423.

Chinese Journal of Pharmaceutical Analysis ›› 2026, Vol. 46 ›› Issue (3) : 415-423. DOI: 10.16155/j.0254-1793.2025-0494
Special Column on Quality Analysis and Research of Proprietary Chinese Medicines in National Drug Sampling and Testing

Quality analysis of proprietary Chinese medicines containing ginseng (red ginseng) based on 2021—2024 national drug sampling and testing*

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 46(3): 415-423 https://doi.org/10.16155/j.0254-1793.2025-0494

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Journal of Pharmaceutical Analysis, All Rights Reserved.
E-mail：ywfx@nifdc.org.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉